Skip to main content
  • Policy
    Get Involved
    Join BIOAction
    View Advocacy Toolkit
    Patient Advocacy
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Become a BIO Member
    Member Directory
    Have a Voice
    Membership Eligibility
    Member Toolkit
    Benefits By Sector
    member health
    Human Health
    member startups
    Startups
    member non R&D
    Non-R&D Companies
    Member Savings
    BBS-Programs-vwr
    VWR, Part of Avantor
    75% off Lab Supplies
    Save with BIO
    Save with BIO
  • News & Insights
    Latest biotech news
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    BIO.News
    I am BIO Podcast
    All News & Insights

    Sign up for the BIO.News Newsletter >

  • Events
    Event Portfolio
    Business Development
    Health
    International
    Professional Development
    Members Only
    All Events
    BIO International Convention

    June 22-25, 2026 | San Diego, CA

    Learn More
    BIO Asia-Taiwan
    BIO Europe

    November 3-5, 2025
    Vienna, Austria

    BIO Investor Forum
    Partnering @JPM Week

    January 12-15, 2026
    San Francisco, CA

    BIO Patient & Health Advocacy Summit
    BIO Investment & Growth Summit

    March 2-3, 2026
    Miami, FL

    BIO Webinars

    Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.

  • About
    About Us
    Learn about our priorities
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
    Diversity & Inclusion >

    Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.

  • Resource Hub
    Latest Resources
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Content Hub
    Biotech News (BIO.News)
    BIO.News Newsletter
    I am BIO Podcast
    BIO Advocacy Toolkit
    Resources Hub
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Webinars
    BIO Microsites
    Clinical Trials: The Power of Participation
    Covid Vaccine Facts
  • Search Results
    Previously Searched
Logo
Logo
Home
Search
  • Policy
    Human HealthPatient AdvocacyInternationalIntellectual PropertyAll Policies
  • Member
    Become a BIO MemberBenefits By Sector
    Human HealthStartupsNon-R&D Companies
    Member DirectoryHave a VoiceMembership EligibilitySavings
  • News & Insights
    Press ReleasesBio.News BlogLetters, Testimony & CommentsAmicus BriefsIndustry Analysis ReportsBiotech JobsEconomic Development Best PracticesIssue BriefsBIO.NewsVideosAll News & Insights
  • Events
    BIO International ConventionBIO Asia-TaiwanAll Events
  • About
    About UsBIO LeadershipDiversity & InclusionBiotech BasicsIndustry RecognitionCareers @ BIO
  • Resource Hub
    Biotech News (BIO.News)BIO.News NewsletterI am BIO PodcastBIO Advocacy ToolkitBIO Early-Stage Resources HubBIO Professional DevelopmentBIO WebinarsClinical Trials: The Power of ParticipationCovid Vaccine Facts
Search Results
Previously Searched
Search Results
Previously Searched
3114 results found
Expand All
Apply All
3114 results found

Letter from BIO, along with 150+ health-focused organizations, to congressional leaders urging passage of the PASTEUR Act
Share
Human Health  •  Letters, Testimony & Comments  •  November 16, 2022

Good Day BIO: Work to do on clinical trial diversity
Share
Good Day BIO Newsletter  •  November 16, 2022
Transparency has improved but more work is needed to achieve diversity in clinical trials. Plus, a podcast gives some good news about biotech and plastic. (631 words, 3 minutes, 9 seconds)
Read More

BIO Partnering at JPM Week 2023 Webinar
Share
Webinars  •  November 16, 2022
Looking for an efficient and effective way to source new partnerships and manage your meetings for JPM Week 2023? View this webinar to learn more about how BIO One-on-One Partnering™ can help. Learn about BIO’s onsite meeting space in San Francisco, how to schedule your meetings with different location options, and a get a first look at the system’s newest feature – optional meeting participants. Also get a sneak peek at how you can stay in-the-know about networking and other opportunities during JPM week. For more information and to register for BIO Partnering at JPM 2023, please visit: https://www.bio.org/events/bio-partnering-jpm/registration. This webinar covers:  Preview of BIO’s onsite meeting space in San Francisco  Partnering best practices & how to schedule your meetings Live demo of the system’s latest feature – optional meeting participants Sneak peak of BIO and Novateur Ventures’ JPM Week Events Guide mobile app Q&A with the host
Read More
772148322.png

BIO Calls for Farm Bill 'Centered on Innovation'
Share
Press Release  •  November 15, 2022
The next farm bill offers an opportunity to examine innovation’s influence on the resiliency of our economy in the face of global challenges, BIO wrote in a statement for the record to the Senate Agriculture Committee's Nov. 15 hearing on energy and rural development programs in the 2023 farm bill, featuring BIO Agriculture and Environment Section Governing Board member Christophe Schilling, Founder and CEO of Geno, as a witness.   “A farm bill centered on innovation stands to incentivize the adoption of cutting-edge technologies and practices, resulting in benefits to the environment and rural economies,” said Beth Ellikidis, BIO’s vice president of agriculture and environment. “Further, supporting biobased technologies, such as sustainable fuels, renewable chemicals and biobased manufacturing, is crucial to agriculture being part of the solution to protecting our climate and fostering energy security.”   The farm bill energy title can build on the Executive Order on Biotechnology and Biomanufacturing, issued by the White House in September, to “catalyze domestic biomanufacturing,” BIO added.   Specific recommendations in BIO’s statement include the following:   BIO recommends the next farm strengthen the BioPreferred® program with significant mandatory funding and enforceable procurement requirements. The Biobased Markets Program or BioPreferred® directs federal agencies to increase purchases and use of renewable chemicals and biobased products.   BIO urges the committee to work with USDA and the Office of Management and Budget to update North American Industry Classification System codes for renewable chemical manufacturers and producers of biobased products.   Dr. Schilling of Geno also testified to the importance of strengthening the BioPreferred program to “meet its goals of spurring economic development, creating new manufacturing jobs and providing new markets for farm commodities.” Dr. Schilling also…
Read More

Geno Testimony to Senate Agriculture Committee on Farm Bill
Share
Agriculture & Environment  •  Letters, Testimony & Comments  •  November 15, 2022

Good Day BIO: More bipartisan opposition to TRIPS expansion
Share
Good Day BIO Newsletter  •  November 15, 2022
The New Democrats coalition express concern about the proposed expansion of the TRIPS waiver—another sign of bipartisan opposition. Plus, BIO member Geno will testify on the 2023 Farm Bill before the Senate Ag Committee today; BIO submitted written testimony. (748 words, 3 minutes, 44 seconds)
Read More

Microbes, Bioplastics … and Art: Solutions to Plastic Pollution
Share
I am BIO Podcast  •  November 15, 2022
Plastic is polluting our waterways and oceans, but biotechnology may deliver solutions. Plant-based bioplastics that can break down in months are one solution. Another is mighty microbes bioengineered to speed up consumption of plastic. This episode spotlights scientists, companies and even a filmmaker and artist who are working in different ways to tackle the growing problem of plastic waste. 
Read More
podcast

BIO Announces Beth Ellikidis as Vice President, Agriculture and Environment
Share
Press Release  •  November 14, 2022
The Biotechnology Innovation Organization (BIO) is pleased to announce that Beth Ellikidis has joined BIO as Vice President, Agriculture and Environment. In her role, Beth will lead the policy and market access strategies for BIO’s Agriculture and Environment section, which includes member companies developing and producing breakthrough technologies in food and agriculture, biobased manufacturing and renewable energy.   “Beth brings to BIO a blend of public policy expertise across the agriculture and health care sectors,” said Rachel King, interim president and CEO of BIO. “Beth’s leadership will be instrumental as we continue to promote new solutions by companies that are working to address all the critical issues we face, from food safety and security to animal health, climate change, and soil and water conservation.”   Beth comes to BIO from the animal health company Zoetis, where she has been head of U.S. public affairs for almost six years. She previously directed public policy for ethanol, energy and renewable products at the National Corn Growers Association and headed up legislative affairs and political advocacy for the National Grain and Feed Association. She was previously legislative director for Rep. Tom Perriello (D-Va.) and legislative assistant for Reps. John Salazar (D-Colo.) and Dennis Cardoza (D-Calif.). Beth earned her master’s degree in political management from the George Washington University, a certificate in global business from Harvard Business School and a bachelor’s degree in government and international politics from George Mason University. Beth grew up on a dairy farm in central Virginia that her father still operates today.   “I’m excited to join BIO, an organization that recognizes the importance of agricultural innovation both today and in our future,” said Beth Ellikidis. “BIO is uniquely positioned to open doors to policy makers, and I’m honored to be part of its work to grow trust in biotechnology and…
Read More

BIO Statement to Senate Ag Committee Hearing on Farm Bill Rural Development & Energy Programs
Share
Agriculture & Environment, Food & Farm Innovation  •  Letters, Testimony & Comments  •  November 14, 2022
BIO submitted a statement for the record to the Senate Committee on Agriculture, Nutrition and Forestry hearing titled "Farm Bill 2023: Rural Development and Energy Programs." BIO called for a "farm bill centered on innovation" to incentivize cutting-edge technologies and practices.
Read More

Good Day BIO: Drug-resistant infections on the rise in healthcare settings
Share
Good Day BIO Newsletter  •  November 14, 2022
A new CDC report highlights an increase in healthcare-associated infections, including two deadly drug-resistant infections that have the industry worried. Plus, food was the focus of COP27 on Saturday, where experts highlighted the need for investment in innovation. (559 words, 2 minutes, 47 seconds)
Read More

Pagination

  • First First page
  • Prev Previous page
  • …
  • 118
  • 119
  • 120
  • …
  • Next Next page
  • Last Last page
Biotechnology Innovation Organization
Explore BIO
Policy
Events
About
Industry Insights
Join Now
BIO PAC
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO International Convention
BIO Partnering at JPM Week
BIO CEO & Investor Conference
BIO Investor Forum
BIO Patient Health & Advocacy Summit
BIO Intellectual Property Counsels Committee Conference
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2025 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO